These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 16741062

  • 1. Endothelin-1 is required during epithelial to mesenchymal transition in ovarian cancer progression.
    Rosanò L, Spinella F, Di Castro V, Decandia S, Nicotra MR, Natali PG, Bagnato A.
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1128-31. PubMed ID: 16741062
    [Abstract] [Full Text] [Related]

  • 2. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
    Bagnato A, Rosanò L.
    Cells Tissues Organs; 2007 Jun; 185(1-3):85-94. PubMed ID: 17587812
    [Abstract] [Full Text] [Related]

  • 3. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
    Rosanò L, Spinella F, Di Castro V, Nicotra MR, Dedhar S, de Herreros AG, Natali PG, Bagnato A.
    Cancer Res; 2005 Dec 15; 65(24):11649-57. PubMed ID: 16357176
    [Abstract] [Full Text] [Related]

  • 4. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells.
    Rosanò L, Cianfrocca R, Spinella F, Di Castro V, Nicotra MR, Lucidi A, Ferrandina G, Natali PG, Bagnato A.
    Clin Cancer Res; 2011 Apr 15; 17(8):2350-60. PubMed ID: 21220476
    [Abstract] [Full Text] [Related]

  • 5. Emerging role of the endothelin axis in ovarian tumor progression.
    Bagnato A, Spinella F, Rosanò L.
    Endocr Relat Cancer; 2005 Dec 15; 12(4):761-72. PubMed ID: 16322321
    [Abstract] [Full Text] [Related]

  • 6. Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells.
    Rosanò L, Varmi M, Salani D, Di Castro V, Spinella F, Natali PG, Bagnato A.
    Cancer Res; 2001 Nov 15; 61(22):8340-6. PubMed ID: 11719468
    [Abstract] [Full Text] [Related]

  • 7. ZD4054, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma cell proliferation.
    Rosanò L, Di Castro V, Spinella F, Decandia S, Natali PG, Bagnato A.
    Exp Biol Med (Maywood); 2006 Jun 15; 231(6):1132-5. PubMed ID: 16741063
    [Abstract] [Full Text] [Related]

  • 8. Mesenchymal transformation in epithelial ovarian tumor cells expressing epidermal growth factor receptor variant III.
    Zeineldin R, Rosenberg M, Ortega D, Buhr C, Chavez MG, Stack MS, Kusewitt DF, Hudson LG.
    Mol Carcinog; 2006 Nov 15; 45(11):851-60. PubMed ID: 16788982
    [Abstract] [Full Text] [Related]

  • 9. Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells.
    Ghoul A, Serova M, Astorgues-Xerri L, Bieche I, Bousquet G, Varna M, Vidaud M, Phillips E, Weill S, Benhadji KA, Lokiec F, Cvitkovic E, Faivre S, Raymond E.
    Cancer Res; 2009 May 15; 69(10):4260-9. PubMed ID: 19417139
    [Abstract] [Full Text] [Related]

  • 10. Antitumor effect of green tea polyphenol epigallocatechin-3-gallate in ovarian carcinoma cells: evidence for the endothelin-1 as a potential target.
    Spinella F, Rosanò L, Decandia S, Di Castro V, Albini A, Elia G, Natali PG, Bagnato A.
    Exp Biol Med (Maywood); 2006 Jun 15; 231(6):1123-7. PubMed ID: 16741061
    [Abstract] [Full Text] [Related]

  • 11. Epithelial-mesenchymal transition in ovarian cancer.
    Vergara D, Merlot B, Lucot JP, Collinet P, Vinatier D, Fournier I, Salzet M.
    Cancer Lett; 2010 May 01; 291(1):59-66. PubMed ID: 19880243
    [Abstract] [Full Text] [Related]

  • 12. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells.
    Spinella F, Rosanò L, Di Castro V, Decandia S, Nicotra MR, Natali PG, Bagnato A.
    Cancer Res; 2007 Feb 15; 67(4):1725-34. PubMed ID: 17308114
    [Abstract] [Full Text] [Related]

  • 13. Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells.
    Kajiyama H, Shibata K, Terauchi M, Yamashita M, Ino K, Nawa A, Kikkawa F.
    Int J Oncol; 2007 Aug 15; 31(2):277-83. PubMed ID: 17611683
    [Abstract] [Full Text] [Related]

  • 14. Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells.
    Yang AD, Camp ER, Fan F, Shen L, Gray MJ, Liu W, Somcio R, Bauer TW, Wu Y, Hicklin DJ, Ellis LM.
    Cancer Res; 2006 Jan 01; 66(1):46-51. PubMed ID: 16397214
    [Abstract] [Full Text] [Related]

  • 15. ABT-627, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma growth in vitro.
    Salani D, Rosanò L, Di Castro V, Spinella F, Venuti A, Padley RJ, Nicotra MR, Natali PG, Bagnato A.
    Clin Sci (Lond); 2002 Aug 01; 103 Suppl 48():318S-321S. PubMed ID: 12193113
    [Abstract] [Full Text] [Related]

  • 16. Epithelial-mesenchymal transition of ovarian tumor cells induces an angiogenic monocyte cell population.
    Collino F, Revelli A, Massobrio M, Katsaros D, Schmitt-Ney M, Camussi G, Bussolati B.
    Exp Cell Res; 2009 Oct 15; 315(17):2982-94. PubMed ID: 19538958
    [Abstract] [Full Text] [Related]

  • 17. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis.
    Christiansen JJ, Rajasekaran AK.
    Cancer Res; 2006 Sep 01; 66(17):8319-26. PubMed ID: 16951136
    [Abstract] [Full Text] [Related]

  • 18. The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression.
    Wu C, Cipollone J, Maines-Bandiera S, Tan C, Karsan A, Auersperg N, Roskelley CD.
    Differentiation; 2008 Feb 01; 76(2):193-205. PubMed ID: 17608733
    [Abstract] [Full Text] [Related]

  • 19. Epithelio-mesenchymal transition in a neoplastic ovarian epithelial hybrid cell line.
    Maines-Bandiera SL, Huntsman D, Lestou VS, Kuo WL, Leung PC, Horsman RD, Wong AS, Woo MM, Choi KK, Roskelley CD, Auersperg N.
    Differentiation; 2004 Apr 01; 72(4):150-61. PubMed ID: 15157238
    [Abstract] [Full Text] [Related]

  • 20. Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer.
    Li HZ, Wang Y, Gao Y, Shao J, Zhao XL, Deng WM, Liu YX, Yang J, Yao Z.
    Mol Cancer Res; 2008 Jun 01; 6(6):917-28. PubMed ID: 18567796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.